Ignite Creation Date:
2024-07-17 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06462716
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-12
Brief Title:
A Phase l Study of By101298 an Oral DNA-PK Inhibitor in Patients With Advanced Solid Tumors
Sponsor:
Chengdu Baiyu Pharmaceutical Co Ltd
Organization:
Chengdu Baiyu Pharmaceutical Co Ltd
Organization Data
Organization:
Chengdu Baiyu Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
BY1298-I-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chengdu Baiyu Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None